Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery

Abstract Background Schizophrenia is mostly a chronic disorder whose symptoms include psychosis, negative symptoms and cognitive dysfunction. Poor adherence is common and related relapse can impair outcomes. Long-acting injectable antipsychotics (LAIs) may promote treatment adherence and decrease th...

Full description

Bibliographic Details
Main Authors: Celso Arango, Andrea Fagiolini, Philip Gorwood, John M. Kane, Sergio Diaz-Mendoza, Navdeep Sahota, Christoph U. Correll
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Psychiatry
Subjects:
Schizophrenia
Antipsychotics
Long-acting injectable
First episode psychosis
Early-phase schizophrenia
Functional recovery
Online Access:https://doi.org/10.1186/s12888-023-04928-0

Internet

https://doi.org/10.1186/s12888-023-04928-0

Similar Items